Nano-microcapsule basic fibroblast growth factor combined with hypoxia-inducible factor-1 improves random skin flap survival in rats

Chen,Guang‑Jun; Chen,Yi‑Heng; Yang,Xia‑Qing; Li,Zhi‑Jie

doi:10.3892/mmr.2015.4699

Nano-microcapsule basic fibroblast growth factor combined with hypoxia-inducible factor-1 improves random skin flap survival in rats

Authors:
- Guang‑Jun Chen
- Yi‑Heng Chen
- Xia‑Qing Yang
- Zhi‑Jie Li
View Affiliations

Affiliations: Department of Hand and Plastic Surgery, The 2nd Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, P.R. China
Published online on: December 21, 2015 https://doi.org/10.3892/mmr.2015.4699
Pages: 1661-1666

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the effect of nano-microcapsule‑basic fibroblast growth factor (bFGF) combined with hypoxia-inducible factor‑1 (HIF-1) on the random skin flap survival of rats. Male Sprague‑Dawley rats were used to establish the McFarlane flap model and subsequently, all model rats were randomly divided into four groups: Control, bFGF, HIF‑1 and bFGF combined with HIF‑1. The model rats were treated with 2.5 µg/day bFGF and 1.0 µg/day HIF‑1 for 5 days by intraperitoneal injection. On day 5 following treatment, the boundaries between necrotic and surviving regions were significantly inhibited by bFGF combined with HIF‑1. bFGF combined with HIF‑1 inhibited oxidative stresses and inflammatory factors in random skin flap survival of rats. bFGF combined with HIF‑1 also activated the protein expression levels of cyclooxygenase (COX)‑2 and vascular endothelial growth factor (VEGF) in the random skin flap survival of rats. In conclusion, nano‑microcapsule bFGF combined with HIF‑1 prevented random skin flap survival in rats through antioxidative, anti‑inflammatory and activation of the protein expression levels of COX-2 and VEGF.

View Figures

View References

1	Cao B, Wang L, Lin D, Cai L and Gao W: Effects of lidocaine on random skin flap survival in rats. Dermatol Surg. 41:53–58. 2015. View Article : Google Scholar
2	Ghavami A, Nutt MP and Hardy SP: Heat shock protein and high-dose aspirin: Effects on random skin flap survival in a rat model. Ann Plast Surg. 48:60–67. 2002. View Article : Google Scholar : PubMed/NCBI
3	Huemer GM, Froschauer SM, Pachinger T, Kwasny O and Schoffl H: A comparison of pretreatment with a topical combination of nonivamide and nicoboxil and surgical delay in a random pattern skin flap model. J Plast Reconstr Aesthet Surg. 62:914–919. 2009. View Article : Google Scholar
4	Li Q, Gao S, Yu Y, Wang W, Chen X, Wang R, Li T, Wang C, Li X and Wu X: A novel bFGF antagonist peptide inhibits breast cancer cell growth. Mol Med Rep. 6:210–214. 2012.PubMed/NCBI
5	Zhang L, Mai HM, Zheng J, Zheng JW, Wang YA, Qin ZP and Li KL: Propranolol inhibits angiogenesis via downregulating the expression of vascular endothelial growth factor in hemangioma derived stem cell. Int J Clin Exp Pathol. 7:48–55. 2014.
6	Cui K, Zhou X, Luo J, et al: Dual gene transfer of bFGF and PDGF in a single plasmid for the treatment of myocardial infarction. Exp Ther Med. 7:691–696. 2014.PubMed/NCBI
7	Kim DS, Ko JH, Jeon YD, Han YH, Kim HJ, Poudel A, Jung HJ, Ku SK, Kim SJ, Park SH, et al: Ixeris dentata NAKAI Reduces Clinical Score and HIF-1 Expression in Experimental Colitis in Mice. Evid Based Complement Alternat Med. 2013:6712812013.PubMed/NCBI
8	Koukourakis MI, Giatromanolaki A, Chong W, et al: Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1 alpha. Cancer Chemother Pharmacol. 53:8–14. 2004. View Article : Google Scholar
9	Weidemann A, Klanke B, Wagner M, Volk T, Willam C, Wiesener MS, Eckardt KU and Warnecke C: Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction. Biochem J. 409:233–242. 2008. View Article : Google Scholar
10	Lee SH, Lee JH, Yoo SY, Hur J, Kim HS and Kwon SM: Hypoxia inhibits cellular senescence to restore the therapeutic potential of old human endothelial progenitor cells via the hypoxia-inducible factor-1α-TWIST-p21 axis. Arterioscler Thromb Vasc Biol. 33:2407–2414. 2013. View Article : Google Scholar : PubMed/NCBI
11	Ren H, Lin D, Mou Z and Dong P: The adverse effect of selective cyclooxygenase-2 inhibitor on random skin flap survival in rats. PLoS One. 8:e828022013. View Article : Google Scholar : PubMed/NCBI
12	Nakamura M, Oda M, Inoue J, Ito T, Akiba Y, Kitajima M, Tsuchiya M and Ishii H: Plasticity of myofibroblasts appearing in granulation tissues after acetic acid treatment. Effect of bFGF Dig Dis Sci. 40:2477–2480. 1995. View Article : Google Scholar
13	Wang TT, Yuan Y, Kang Y, Yuan WL, Zhang HT, Wu LY and Feng ZT: Effects of acupuncture on the expression of glial cell line-derived neurotrophic factor (GDNF) and basic fibroblast growth factor (FGF-2/bFGF) in the left sixth lumbar dorsal root ganglion following removal of adjacent dorsal root ganglia. Neurosci Lett. 382:236–241. 2005. View Article : Google Scholar : PubMed/NCBI
14	Mohideen MA, Hruska-Hageman A and Nilsen-Hamilton M: A unique bFGF-responsive transcriptional element. Gene. 237:81–90. 1999. View Article : Google Scholar : PubMed/NCBI
15	Fayazzadeh E, Ahmadi SH, Rabbani S, Boroumand MA, Salavati A and Anvari MS: A comparative study of recombinant human basic fibroblast growth factor (bFGF) and erythropoietin (EPO) in prevention of skin flap ischemic necrosis in rats. Arch Iran Med. 15:553–556. 2012.PubMed/NCBI
16	Wang F, Chang M, Shi Y, Jiang L, Zhao J, Hai L, Sharen G and Du H: Downregulation of hypoxia-inducible factor-1 suppresses malignant biological behavior of triple-negative breast cancer cells. Int J Clin Exp Med. 7:3933–3940. 2014.
17	Nanduri J, Vaddi DR, Khan SA, Wang N, Makarenko V, Semenza GL and Prabhakar NR: HIF-1α activation by intermittent hypoxia requires NADPH oxidase stimulation by xanthine oxidase. PLoS One. 10:e01197622015. View Article : Google Scholar
18	Koçer G, Nazıroğlu M, Çelik Ö, Önal L, Özçelik D, Koçer M and Sönmez TT: Basic fibroblast growth factor attenuates bisphosphonate-induced oxidative injury but decreases zinc and copper levels in oral epithelium of rat. Biol Trace Elem Res. 153:251–256. 2013. View Article : Google Scholar : PubMed/NCBI
19	Wang Z, Zhang H, Xu X, Shi H, Yu X, Wang X, Yan Y, Fu X, Hu H, Li X, et al: bFGF inhibits ER stress induced by ischemic oxidative injury via activation of the PI3K/Akt and ERK1/2 pathways. Toxicol Lett. 212:137–146. 2012. View Article : Google Scholar : PubMed/NCBI
20	Tasso R, Gaetani M, Molino E, Cattaneo A, Monticone M, Bachi A and Cancedda R: The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model. Biomaterials. 33:2086–2096. 2012. View Article : Google Scholar
21	Rodriguez-Miguelez P, Lima-Cabello E, Martínez-Flórez S, Almar M, Cuevas MJ and González-Gallego J: Hypoxia-inducible factor-1 modulates the expression of vascular endothelial growth factor and endothelial nitric oxide synthase induced by eccentric exercise. J Appl Physiol (1985). 118:1075–1083. 2015. View Article : Google Scholar
22	Liu L, Zhang J, Li M, Zhang X, Zhang J, Li Z, Wang L, Wu J and Luo C: Inhibition of HepG2 cell proliferation by ursolic acid and polysaccharides via the downregulation of cyclooxygenase-2. Mol Med Rep. 9:2505–2511. 2014.PubMed/NCBI
23	Gallindo RM, Gonçalves FL, Figueira RL, Pereira LA, Simões AL, Schmidt AF and Sbragia L: Ventilation causes pulmonary vascular dilation and modulates the NOS and VEGF pathway on newborn rats with CDH. J Pediatr Surg. 50:842–848. 2015. View Article : Google Scholar : PubMed/NCBI
24	Erdem H, Yildirim U, Uzunlar AK, Cam K, Tekin A, Kayikci MA, Sahiner C, Oktay M, Ankarali H and Aydin LY: Relationship among expression of basic-fibroblast growth factor, MTDH/astrocyte elevated gene-1, adenomatous polyposis coli, matrix metalloproteinase 9, and COX-2 markers with prognostic factors in prostate carcinomas. Niger J Clin Pract. 16:418–423. 2013. View Article : Google Scholar : PubMed/NCBI
25	Seo Y, Ji YW, Lee SM, Shim J, Noh H, Yeo A, Park C, Park MS and Chang EJ: Lee HKL Activation of HIF-1α (hypoxia inducible factor-1α) prevents dry eye-induced acinar cell death in the lacrimal gland. Cell Death Dis. 5:e13092014. View Article : Google Scholar
26	Hong JP, Li XM, Li MX and Zheng FL: VEGF suppresses epithelial-mesenchymal transition by inhibiting the expression of Smad3 and miR192, a Smad3-dependent microRNA. Int J Mol Med. 31:1436–1442. 2013.PubMed/NCBI
27	Kranz A, Rau C, Kochs M and Waltenberger J: Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance. J Mol Cell Cardiol. 32:65–72. 2000. View Article : Google Scholar : PubMed/NCBI
28	Chen T, Ren Z, Ye LC, Zhou PH, Xu JM, Shi Q, Yao LQ and Zhong YS: Factor inhibiting HIF1α (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1α pathway. Cancer Biol Ther. 16:244–252. 2015. View Article : Google Scholar
29	Tzeng HE, Chen PC, Lin KW, Lin CY, Tsai CH, Han SM, Teng CL, Hwang WL, Wang SW and Tang CH: Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cells-primed angiogenesis. Clin Sci (Lond). 129:147–158. 2015. View Article : Google Scholar